Guidelines Detail

NCCN Guidelines

Breast Cancer

Guidelines

NCCN Guidelines Version 5.2023

- Ductal Carcinoma in situ (DCIS)

- Invasive Breast Cancer

- Special consideration: Breast Cancer During Pregnancy

- Special consideration: Inflammatory Breast Cancer

- Special consideration: Paget Disease

- Special consideration: Phyllodes Tumor

Evidence Blocks

NCCN Guidelines with Evidence Blocks Version 4.2023

Frameworks

Basic Resources (English) Version 4.2022
Core Resources (English) Version 4.2022
Enhanced Resources (English) Version 4.2022

Guidelines for Patients

Invasive Breast Cancer-English Version 2023
Metastatic Breast Cancer-English Version 2023
DCIS Breast Cancer-English Version 2023
Inflammatory Breast Cancer-English Version 2023
DCIS Breast Cancer-Spanish - Latin America Version 2023
Metastatic Breast Cancer-Spanish - Latin America Version 2023
Invasive Breast Cancer-Spanish - Latin America Version 2023
Inflammatory Breast Cancer-Spanish - Latin America Version 2023
Metastatic Breast Cancer-Ukrainian Version 2020
DCIS Breast Cancer-Ukrainian Version 2020
Invasive Breast Cancer-Ukrainian Version 2020

Educational Events and Programs

Calendar of Events

Continuing Education

International

Translations

Chinese Version 4.2022
French Version 8.2021
Italian Version 2.2022
Japanese Version 5.2020
Korean Version 6.2020
Polish Version 6.2020
Portuguese Version 6.2020
Spanish Version 2.2022
Ukrainian Version 2.2022

Adaptations

English (European/Spain) Version 3.2019
English (Middle East & North Africa) Version 2.2023
English (European/Poland) Version 4.2023

Harmonized

English (Caribbean) Version 1.2018
English (Africa) Version 4.2021

Disclosures